Robert A. Goodnow

3.9k total citations · 3 hit papers
60 papers, 2.7k citations indexed

About

Robert A. Goodnow is a scholar working on Molecular Biology, Organic Chemistry and Microbiology. According to data from OpenAlex, Robert A. Goodnow has authored 60 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Organic Chemistry and 9 papers in Microbiology. Recurrent topics in Robert A. Goodnow's work include Chemical Synthesis and Analysis (13 papers), Computational Drug Discovery Methods (8 papers) and Bacterial Infections and Vaccines (7 papers). Robert A. Goodnow is often cited by papers focused on Chemical Synthesis and Analysis (13 papers), Computational Drug Discovery Methods (8 papers) and Bacterial Infections and Vaccines (7 papers). Robert A. Goodnow collaborates with scholars based in United States, Switzerland and United Kingdom. Robert A. Goodnow's co-authors include Anthony D. Keefe, Christoph E. Dumelin, Kazuki Nakanishi, P.N.R. Usherwood, Matthias Zentgraf, Jasmin Fisher, Jennifer Listgarten, Petra Schneider, Johanna M. Jansen and José S. Duca and has published in prestigious journals such as Nature Reviews Drug Discovery, Biochemistry and Journal of Bacteriology.

In The Last Decade

Robert A. Goodnow

60 papers receiving 2.5k citations

Hit Papers

Rethinking ... 1980 2026 1995 2010 2019 2016 1980 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Goodnow United States 24 1.5k 620 441 412 246 60 2.7k
Marc A. Giulianotti United States 30 2.3k 1.5× 931 1.5× 724 1.6× 843 2.0× 99 0.4× 108 3.6k
David L. Pompliano United States 23 3.2k 2.1× 930 1.5× 238 0.5× 640 1.6× 388 1.6× 36 5.1k
Sun Choi South Korea 29 2.0k 1.3× 585 0.9× 115 0.3× 633 1.5× 119 0.5× 120 3.5k
Xiayang Qiu United States 34 2.4k 1.6× 804 1.3× 194 0.4× 266 0.6× 697 2.8× 61 4.9k
Francesca Mancini Italy 37 1.4k 0.9× 530 0.9× 230 0.5× 653 1.6× 232 0.9× 121 4.0k
Ping‐Chiang Lyu Taiwan 35 2.4k 1.6× 284 0.5× 217 0.5× 120 0.3× 97 0.4× 137 3.5k
Grant R. Zimmermann United States 13 2.0k 1.3× 313 0.5× 134 0.3× 684 1.7× 116 0.5× 15 3.0k
Rajendra Kumar Sweden 12 2.3k 1.5× 748 1.2× 89 0.2× 1.1k 2.8× 188 0.8× 20 4.1k
Jung‐Hsin Lin Taiwan 24 1.7k 1.1× 284 0.5× 64 0.1× 585 1.4× 175 0.7× 61 2.4k
Michael T. Marty United States 29 2.3k 1.5× 413 0.7× 96 0.2× 997 2.4× 128 0.5× 92 4.1k

Countries citing papers authored by Robert A. Goodnow

Since Specialization
Citations

This map shows the geographic impact of Robert A. Goodnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Goodnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Goodnow more than expected).

Fields of papers citing papers by Robert A. Goodnow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Goodnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Goodnow. The network helps show where Robert A. Goodnow may publish in the future.

Co-authorship network of co-authors of Robert A. Goodnow

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Goodnow. A scholar is included among the top collaborators of Robert A. Goodnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Goodnow. Robert A. Goodnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodnow, Robert A. & Christopher P. Davie. (2017). Chapter One - DNA-Encoded Library Technology: A Brief Guide to Its Evolution and Impact on Drug Discovery. 1–15. 1 indexed citations
2.
Fuller, Nathan O., Loredana Spadola, Scott D. Cowen, et al.. (2016). An improved model for fragment-based lead generation at AstraZeneca. Drug Discovery Today. 21(8). 1272–1283. 58 indexed citations
3.
Gillespie, Paul, Michael C. Myers, Karin Conde‐Knape, et al.. (2014). Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(12). 2707–2711. 2 indexed citations
4.
Gillespie, Paul, Robert A. Goodnow, Gopal Bose, et al.. (2013). Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(3). 949–953. 13 indexed citations
5.
Goodnow, Robert A. & Paul Gillespie. (2007). 1Hit and Lead Identification: Efficient Practices for Drug Discovery. Progress in medicinal chemistry. 45. 1–61. 9 indexed citations
6.
Wang, Zhenyu, Shiming Li, Stephen B. Ferguson, Robert A. Goodnow, & Chi‐Tang Ho. (2007). Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts. Journal of Separation Science. 31(1). 30–37. 31 indexed citations
8.
Fotouhi, Nader, et al.. (2006). Application and Utilization of Chemoinformatics Tools in Lead Generation and Optimization. Combinatorial Chemistry & High Throughput Screening. 9(2). 95–102. 1 indexed citations
9.
Goodnow, Robert A.. (2001). Current practices in generation of small molecule new leads. Journal of Cellular Biochemistry. 84(S37). 13–21. 17 indexed citations
10.
Goodnow, Robert A., et al.. (1993). The sugars in chromomycin A3 stabilize the magnesium(2+)-dimer complex. Biochemistry. 32(2). 463–471. 33 indexed citations
11.
Brundell, Patrick, et al.. (1991). Quisqualate-sensitive glutamate receptors of the locust Schistocerca gregaria are antagonised by intracellularly applied philanthotoxin and spermine. Neuroscience Letters. 131(2). 196–200. 13 indexed citations
12.
Goodnow, Robert A., et al.. (1991). Inactivation of a quisqualate-sensitive glutamate receptor by photosensitive analogues of philanthotoxin. Neuroscience Letters. 125(1). 62–64. 7 indexed citations
13.
Goodnow, Robert A., Kazuki Nakanishi, P.N.R. Usherwood, et al.. (1991). Synthesis and binding of [125I2]philanthotoxin-343, [125I2]philanthotoxin-343-lysine, and [125I2]philanthotoxin-343-arginine to rat brain membranes. Journal of Medicinal Chemistry. 34(8). 2389–2394. 21 indexed citations
14.
Brackley, Philip, et al.. (1990). Spermine and philanthotoxin potentiate excitatory amino acid responses of Xenopus oocytes injected with rat and chick brain RNA. Neuroscience Letters. 114(1). 51–56. 83 indexed citations
15.
Goodnow, Robert A., et al.. (1990). Subacute inhalation toxicity study of an ice-nucleation-active Pseudomonas syringae administered as a respirable aerosol to rats. Toxicology Letters. 54(2-3). 157–167. 11 indexed citations
16.
Kenny, Peter T.M., Robert A. Goodnow, Katsuhiro Konno, & Koji Nakanishi. (1989). Philanthotoxins. A mass spectrometric investigation. Rapid Communications in Mass Spectrometry. 3(9). 295–297. 6 indexed citations
17.
19.
Goodnow, Robert A., et al.. (1979). Efficacy of Bordetella bronchiseptica Bacterin in Controlling Enzootic Atrophic Rhinitis in Swine. American Journal of Veterinary Research. 40(1). 58–60. 13 indexed citations
20.
Goodnow, Robert A., et al.. (1979). Intranasal Immunization of Dogs Against Bordetella bronchiseptica-Induced Tracheobronchitis (Kennel Cough) with Modified Live-Bordetella bronchiseptica Vaccine. American Journal of Veterinary Research. 40(9). 1241–1243. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026